Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved

References

• Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol. 2008;43:1232–1240.
   PubMed Web of Science ®Google Scholar
• Grønbaek L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60:612–617.
   PubMed Web of Science ®Google Scholar
• Mohamadnejad M, Malekzadeh R, Nasseri-Moghaddam S, et al. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis. Dig Dis Sci. 2005;50:547–551.
   PubMed Web of Science ®Google Scholar
• Mottershead M, Neuberger J. Transplantation in autoimmune liver diseases. World J Gastroenterol. 2008;14:3388–3395.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Carpenter HA. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology. 2004;39:1631–1638.
   PubMed Web of Science ®Google Scholar
• Soloway RD, Summerskill WH, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972;63:820–833.
   PubMed Web of Science ®Google Scholar
• Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996;110:848–857.
   PubMed Web of Science ®Google Scholar
• Kanzler S, Löhr H, Gerken G, et al. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol. 2001;39:339–341, 344–348.
   PubMed Web of Science ®Google Scholar
• van Gerven NMF, Verwer BJ, Witte BI, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol. 2013;58:141–147.
   PubMed Web of Science ®Google Scholar
• Kim D, Eshtiaghpour D, Alpern J, et al. Access to primary care is associated with better autoimmune hepatitis outcomes in an urban county hospital. BMC Gastroenterol. 2015;15. [cited 2017 Mar 19]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517362/ PMCID: PMC4517362.
   Web of Science ®Google Scholar
• Zahiruddin A, Farahmand A, Gaglio P, et al. Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino population. Gastroenterol Hepatol Bed Bench. 2016;9:225–230.
   PubMedGoogle Scholar
• Lim KN, Casanova RL, Boyer TD, et al. Autoimmune hepatitis in African Americans: presenting features and response to therapy. Am J Gastroenterol. 2001;96:3390–3394.
   PubMed Web of Science ®Google Scholar
• Nguyen D, Hu KQ. Clinical presentation of autoimmune hepatitis in Asian Americans: a case series study. Am J Gastroenterol. 2013;108:S136.
   Web of Science ®Google Scholar
• Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology. 2007;46:1828–1835.
   PubMedGoogle Scholar
• Sadri L, Puchakayala B, Sanivarapu R, et al. Ethnicity differences and outcomes for patients with autoimmune hepatitis: a single community center experience. Am J Gastroenterol. 2015;110:S878–S879.
   Web of Science ®Google Scholar
• Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol. 2010;25:1681–1686.
   PubMed Web of Science ®Google Scholar
• Yang F, Wang Q, Bian Z, et al. Autoimmune hepatitis: east meets west. J Gastroenterol Hepatol. 2015;30:1230–1236.
   PubMed Web of Science ®Google Scholar
• D'Souza R, Sinnott P, Glynn MJ, et al. An unusual form of autoimmune hepatitis in young Somalian men. Liver Int. 2005;25:325–330.
   PubMed Web of Science ®Google Scholar
• Borssén ÅD, Marschall H-U, Bergquist A, et al. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis. Scand J Gastroenterol. 2017;52:1022–1028.
   PubMed Web of Science ®Google Scholar
• Tana MM, Holt EW, Wong RJ, et al. Autoimmune hepatitis disproportionately affects people of color. Hepatology. 2015;62:366A–367A.
   Google Scholar
• Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.
   PubMed Web of Science ®Google Scholar
• Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–938.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research Electronic Data Capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017. Available from: https://www.R-project.org/
   Google Scholar
• Carrion AF, Ghanta R, Carrasquillo O, et al. Chronic liver disease in the Hispanic population of the United States. Clin Gastroenterol Hepatol. 2011;9:834–e110.
   PubMed Web of Science ®Google Scholar
• Kim D, Eshtiaghpour D, Alpern J. Autoimmune hepatitis outcomes in an urban county hospital with a largely Hispanic population. Am J Gastroenterol. 2013;108:S137.
   Web of Science ®Google Scholar
• Kim TI, Kagihara JE, Tsai NC, et al. Autoimmune Hepatitis in Hawai'i. Hawaii J Med Public Health. 2015;74:270–274.
   PubMedGoogle Scholar
• Wen J, Wong RJ, Somsouk M, et al. Black and Latino race/ethnicity increase the risk of hospitalization for autoimmune hepatitis in the United States. Hepatology. 2016;63:820A.
   Google Scholar
• Munoz-Espinosa LE, Cordero-Perez P, Cura-Esquivel I, et al. Autoimmune hepatitis in Mexican patients. J Clin Gastroenterol. 2013;47:372.
   PubMed Web of Science ®Google Scholar
• Huang M, Donet-Mostacero J, Martin P, et al. Impact of gender, race, and ethnicity in the clinical presentation and outcomes of autoimmune hepatitis. Am J Gastroenterol. 2014;109:S161.
   PubMed Web of Science ®Google Scholar
• Wong RJ, Gish R, Frederick T, et al. The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis. J Clin Gastroenterol. 2012;46:155–161.
   PubMed Web of Science ®Google Scholar
• Than NN, Mann J, Gupta R, et al. Comparison of type 1 autoimmune hepatitis patients’ characteristic in Caucasian, Asian and black ethnic groups: a single centre experience. Gut. 2014;63:A191.
   PubMed Web of Science ®Google Scholar
• Williams EM, Bruner L, Adkins A, et al. I too, am America: a review of research on systemic lupus erythematosus in African-Americans. Lupus Sci Med. 2016;3:e000144.
   PubMedGoogle Scholar
• Molokhia M, McKeigue P. Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res. 2000;2:115–125.
   PubMedGoogle Scholar
• Pons-Estel GJ, Catoggio LJ, Cardiel MH, et al. Lupus in Latin-American patients: lessons from the GLADEL cohort. Lupus. 2015;24:536–545.
   PubMed Web of Science ®Google Scholar
• Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford). 2017;56:i67–i77.
   PubMed Web of Science ®Google Scholar
• Levy C, Naik J, Giordano C, et al. Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics. Clin Gastroenterol Hepatol. 2014;12:1398–1405.
   PubMed Web of Science ®Google Scholar
• Mijovic CH, Penny MA, Jenkins D, et al. The insulin gene region and susceptibility to insulin-dependent diabetes mellitus in four races; new insights from Afro-Caribbean race-specific haplotypes. Autoimmunity. 1997;26:11–22.
   PubMed Web of Science ®Google Scholar
• Kong KF, Yeap SS, Chow SK, et al. HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity. 2002;35:235–239.
   PubMed Web of Science ®Google Scholar
• Xiao J-P, Wang X-R, Zhang S, et al. Association between rs6887695 and 3′-untranslated region polymorphisms within the interleukin-12B gene and susceptibility to autoimmune diseases in Asian and European population: a meta-analysis. Autoimmunity. 2016;49:277–284.
   PubMed Web of Science ®Google Scholar
• Sewell JL, Velayos FS. Systematic review: the role of race and socioeconomic factors on IBD healthcare delivery and effectiveness. Inflamm Bowel Dis. 2013;19:627–643.
   PubMed Web of Science ®Google Scholar
• Afzali A, Cross RK. Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis. 2016;22:2023–2040.
   PubMed Web of Science ®Google Scholar
• Crosslin KL, Wiginton KL. The impact of race and ethnicity on disease severity in systemic lupus erythematosus. Ethn Dis. 2009;19:301.
   PubMed Web of Science ®Google Scholar
• Gandhi K, Tosur M, Schaub R, et al. Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes. Diabet Med. 2017;34:1435–1439.
   PubMed Web of Science ®Google Scholar
• Hall WJ, Chapman MV, Lee KM, et al. Implicit racial/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review. Am J Public Health. 2015;105:e60–e76.
   PubMed Web of Science ®Google Scholar
• Lattimer LD, Chandler MB, Borum ML. Hispanics and inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1214–1218.
   PubMed Web of Science ®Google Scholar